Trevi Therapeutics, Inc. - COM (TRVI)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / COM
Number of holders
35
Total Shares
43.5M
Shares change
+277K
Total reported value, excl. options
$80.4M
Value change
+$499K
Put/Call ratio
43.09
Number of buys
14
Number of sells
-12
Price
$1.85
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.